Back to results
US 12,502,399 B2Granted
Compositions and therapeutic methods for treating chronic sequalae following viral infections
OwnerJean-Jacques Schochinventor
Life of this patent
Estimating the term…
Abstract
Embodiments of therapeutic protocols to treat Post-Acute Sequelae SARS-CoV-2 infection (“PASC”), a.k.a. “long Covid,” are described. The PASC treatment protocols focus on a moderating a hyperimmune response; destroying and removing the SARS CoV-2 spike protein from the gut and body, detoxifying the body and the brain; replenishing key nutrients; mitigating depression and anxiety; and a regimen of physical and mental exercises. A standard six-week protocol and a shorter, three-week protocol are disclosed for those with a milder form of PASC are disclosed.
Claims17
A method for treating post-Covid syndrome comprising:
- administering a first compositional blend comprising (i) an infusion (tea) of Cistus incanus, (ii) quercetin, (iii) Andrographis paniculata, (iv) nicotinamide mononucleotide, and (v) curcumin;
- administering a second composition comprising gum benzoin, Jugulans nigra hull, Inonotus obliquus, and Trametes versicolor;
- administering a third composition comprising zeolite, Desmodium molliculum, and Pimpinella anisum;
- administering a fourth composition comprising nicotinamide riboside, pterostilbene, Panax quinquefolius, and Withania somnifera;
- and
- administering a fifth composition comprising psilocybin and Hericium erinaceus.
3 more elements
Dependencies are inferred from the claim text.